Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-14-061462

Director sold 50,000 shares at $0.24 ($11,840)

  • Director acquired 50,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kraus Al Director 2014-10-14 Option exercise +50,000 $0.04 $1,750 1,443,631 D: show line 1 in the form
Kraus Al Director 2014-10-14 Sale −50,000 $0.24 $11,840 1,393,631 D: show line 2 in the form
Open-market sales · 50,000 sh · avg $0.24 · $11,840

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Kraus Al Director 2014-10-14 Option exercise · Stock Option −50,000 6,019,328 D: show line 3 in the form
Loading xslF345X03/v391497_4.xml…